JD Health Sets 13 Aug 2026 Board Meeting to Approve H1 2026 Results and Discuss Interim Dividend

Bulletin Express

07/31

JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend for shareholders.

Management will host an earnings call on the same day at 17:00 (Beijing/Hong Kong Time) to present the half-year performance and respond to investor questions. Dial-in access will be available for participants in Mainland China, Hong Kong, the United States and Singapore, with separate passcodes for Mandarin and English channels.

The board currently comprises one executive director, one non-executive director and five independent non-executive directors. The announcement was issued in Hong Kong on 31 July 2026 and signed by Executive Director Mr. Dong Cao.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1105175212"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1105175212\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1105175212?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-31 18:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1105175212","market":"hk","top_or_hot":-1,"title":"JD Health Sets 13 Aug 2026 Board Meeting to Approve H1 2026 Results and Discuss Interim Dividend","media":"Bulletin Express","content":"<p>JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend for shareholders.</p>\n<p>Management will host an earnings call on the same day at 17:00 (Beijing/Hong Kong Time) to present the half-year performance and respond to investor questions. Dial-in access will be available for participants in Mainland China, Hong Kong, the United States and Singapore, with separate passcodes for Mandarin and English channels.</p>\n<p>The board currently comprises one executive director, one non-executive director and five independent non-executive directors. The announcement was issued in Hong Kong on 31 July 2026 and signed by Executive Director Mr. Dong Cao.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JD Health Sets 13 Aug 2026 Board Meeting to Approve H1 2026 Results and Discuss Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJD Health Sets 13 Aug 2026 Board Meeting to Approve H1 2026 Results and Discuss Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-31 18:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend for shareholders.</p>\n<p>Management will host an earnings call on the same day at 17:00 (Beijing/Hong Kong Time) to present the half-year performance and respond to investor questions. Dial-in access will be available for participants in Mainland China, Hong Kong, the United States and Singapore, with separate passcodes for Mandarin and English channels.</p>\n<p>The board currently comprises one executive director, one non-executive director and five independent non-executive directors. The announcement was issued in Hong Kong on 31 July 2026 and signed by Executive Director Mr. Dong Cao.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1105175212","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1105175212","pubTimestamp":1785492254,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"京东健康定于 2026 年 8 月 13 日召开董事会会议，批准 2026 年上半年业绩并讨论中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health announced that its board of directors will convene on 13 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The agenda also includes deliberation on a potential interim dividend for shareholders.\nManagement will host an earnings call on the same day at 17:00 (Beijing/Hong Kong Time) to present the half-year performance and respond to investor questions. Dial-in access will be available for participants in Mainland China, Hong Kong, the United States and Singapore, with separate passcodes for Mandarin and English channels.\nThe board currently comprises one executive director, one non-executive director and five independent non-executive directors. The announcement was issued in Hong Kong on 31 July 2026 and signed by Executive Director Mr. Dong Cao.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}